We are excited to invite you to the 2nd edition of the Cardiometabolic, Renal, Liver, and Obesity Conference (CaReMeLO 2025), taking place in Warsaw, Poland, on 30-31 May 2025.
Following the tremendous success of the inaugural CaReMe-O conference in Spain in 2024, which saw over 1000 participants (250 onsite and 750 online), we are building on this momentum to further empower family physicians in the comprehensive management of cardiometabolic, renal, liver, and obesity conditions. This year, we are placing a greater emphasis on cutting-edge therapies, such as GLP-1 receptor agonists like Trizepatide and Wegovy, which are transforming obesity treatment.
The 2025 edition promises to deliver an even more dynamic and impactful experience, incorporating feedback from last year. Expect more interactive sessions, practical real world case studies, and enriched networking opportunities, as well as deeper explorations of the latest treatments and innovations in managing obesity and liver disease.
This conference is vital for family physicians, general practitioners, nurse practitioners, and specialists in endocrinology, cardiology, and nephrology. If you are involved in managing patients with cardiometabolic and obesity syndromes, this event is designed for you.
Join us in Warsaw to explore innovative strategies and strengthen your expertise in managing CaReMeLO syndromes. This is your opportunity to make a lasting impact on patient care and outcomes. Stay tuned for more details about this essential event for primary care providers and specialists.
